CTOR·17331Y109·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
CTOR (CITIUS ONCOLOGY INC) is held by 8 institutional investors as of Q1 2026. Largest holders: BANK OF AMERICA CORP /DE/ ($2.4M), GEODE CAPITAL MANAGEMENT, LLC ($164,107), BlackRock, Inc. ($29,417). Net institutional sentiment: Mixed.
See how CTOR's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer